Literature DB >> 24663053

Milestones in the use of combined-modality radiation therapy and chemotherapy.

Theodore S Lawrence1, Bruce G Haffty, Jay R Harris.   

Abstract

Mesh：

Year:  2014        PMID： 24663053     DOI： 10.1200/JCO.2014.55.2281

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

Review 1.  Personalized radiotherapy: concepts, biomarkers and trial design.

Authors:  A H Ree; K R Redalen
Journal:  Br J Radiol       Date:  2015-05-20       Impact factor: 3.039

Review 2.  Capacity of gold nanoparticles in cancer radiotherapy.

Authors:  Nadeem M S Nagi; Yasir A M Khair; Ahmed M E Abdalla
Journal:  Jpn J Radiol       Date:  2017-08-09       Impact factor: 2.374

3.  Enhancing the efficacy of radiation therapy: premises, promises, and practicality.

Authors:  C Norman Coleman; Theodore S Lawrence; David G Kirsch
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

4.  Cerenkov-Activated Sticky Tag for In Vivo Fluorescence Imaging.

Authors:  Sudeep Das; Katja Haedicke; Jan Grimm
Journal:  J Nucl Med       Date:  2017-09-14       Impact factor: 10.057

Review 5.  Integrating nanomedicine into clinical radiotherapy regimens.

Authors:  Allison N DuRoss; Megan J Neufeld; Shushan Rana; Charles R Thomas; Conroy Sun
Journal:  Adv Drug Deliv Rev       Date:  2019-07-04       Impact factor: 15.470

6.  Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy.

Authors:  Jiejian Chen; Qiyao Yang; Minchen Liu; Mengting Lin; Tiantian Wang; Zhentao Zhang; Xincheng Zhong; Ningning Guo; Yiying Lu; Jing Xu; Changsheng Wang; Min Han; Qichun Wei
Journal:  Int J Nanomedicine       Date:  2019-10-08

7.  Detection of metastatic tumors after γ-irradiation using longitudinal molecular imaging and gene expression profiling of metastatic tumor nodules.

Authors:  Su Jin Jang; Joo Hyun Kang; Yong Jin Lee; Kwang Il Kim; Tae Sup Lee; Jae Gol Choe; Sang Moo Lim
Journal:  Int J Oncol       Date:  2016-02-08       Impact factor: 5.650

Review 8.  Application of nanotechnology to cancer radiotherapy.

Authors:  Yu Mi; Zhiying Shao; Johnny Vang; Orit Kaidar-Person; Andrew Z Wang
Journal:  Cancer Nanotechnol       Date:  2016-12-19

9.  Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.

Authors:  Jihane Boustani; Elodie Lauret Marie Joseph; Etienne Martin; Salim Benhmida; Benoit Lecoester; Florent Tochet; Céline Mirjolet; Cédric Chevalier; David Thibouw; Noémie Vulquin; Stéphanie Servagi; Xushan Sun; Olivier Adotévi
Journal:  BMC Immunol       Date:  2021-06-18       Impact factor: 3.615

10.  Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy.

Authors:  Elodie Lauret Marie Joseph; Amos Kirilovsky; Benoît Lecoester; Carine El Sissy; Laura Boullerot; Laurie Rangan; Amélie Marguier; Florent Tochet; Magalie Dosset; Jihane Boustani; Patrice Ravel; Romain Boidot; Laurie Spehner; Nacilla Haicheur-Adjouri; Florence Marliot; Jean-René Pallandre; Francis Bonnefoy; Viorel Scripcariu; Marc Van den Eynde; Emmanuel Cornillot; Céline Mirjolet; Franck Pages; Olivier Adotevi
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.